HOME    CORPORATE    CORE TECHNOLOGY    NEWS & EVENTS    INVESTORS    CAREERS    CONTACT  
 
  Welcome to GenKyoTex  
     

 
 

GenKyoTex. An Innovative Approach for the Treatment of Pathologies Associated with Overproduction of Oxygen Radicals

GenKyoTex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals.  Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety and efficacy over existing antioxidants therapy, giving them a significant competitive advantage. GenKyoTex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.



 

 
 
 
Developped by